This came in agreement with Ghosh et al., who reported that miRNA199a could suppresses tumor growth and migration of HCC through inhibiting angiogenesis in by targeting VEGFA, and subsequently inhibiting VEGF secretion (Ghosh et al., 2017). This evidence concerns the gene VEGFA and hepatocellular carcinoma.